These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1592460)

  • 41. Suppressed dopaminergic activity and water-sodium handling in the kidneys at the prehypertensive stage of essential hypertension.
    Iimura O; Shimamoto K
    J Auton Pharmacol; 1990; 10 Suppl 1():s73-7. PubMed ID: 2098378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imbalance of renal production between 5-hydroxytryptamine and dopamine in patients with essential hypertension complicated by microalbuminuria.
    Hirose M; Tomoda F; Koike T; Yamazaki H; Ohara M; Liu H; Kagitani S; Inoue H
    Am J Hypertens; 2013 Feb; 26(2):227-33. PubMed ID: 23382407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intrarenal production of dopamine and natriuresis following DOPA and saline infusions in healthy human volunteers.
    Barendregt JN; Muizert Y; van Nispen tot Pannerden LL; Chang PC
    J Hum Hypertens; 1995 Mar; 9(3):187-94. PubMed ID: 7783100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of lithium on the renal response to the dopamine prodrug gludopa in normal man.
    Jeffrey RF; Macdonald TM; Brown J; Rae PW; Lee MR
    Br J Clin Pharmacol; 1988 Jun; 25(6):725-32. PubMed ID: 2849472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine, the kidney and essential hypertension studies with gludopa.
    Lee MR
    Clin Exp Hypertens A; 1987; 9(5-6):977-86. PubMed ID: 3113781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salt and hypertension: water-sodium handling in essential hypertension.
    Iimura O; Shimamoto K
    Ann N Y Acad Sci; 1993 Mar; 676():105-21. PubMed ID: 8489125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine generated from L-dopa: discrepancy between plasma levels and cardiac effects.
    Tjandramaga TB; Goldberg LI; Anton AH
    Proc Soc Exp Biol Med; 1973 Feb; 142(2):424-8. PubMed ID: 4689374
    [No Abstract]   [Full Text] [Related]  

  • 48. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
    Watanabe AM; Parks LC; Kopin IJ
    J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The renal and haemodynamic effects of a 10 h infusion of glutamyl-L-dopa in normal man.
    MacDonald TM; Jeffrey RF; Lee MR
    Br J Clin Pharmacol; 1989 Jun; 27(6):811-22. PubMed ID: 2527048
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Significance of renal dopamine on pathogenesis of essential hypertension].
    Kohno H
    Nihon Jinzo Gakkai Shi; 1991 Mar; 33(3):311-9. PubMed ID: 2062017
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions between sodium balance, intrarenal dopamine synthesis, and sympathetic activity in HLA-identical kidney donors and recipients.
    Barendregt JN; van Nispen tot Pannerden LL; Chang PC
    Nephrol Dial Transplant; 1995; 10(3):341-8. PubMed ID: 7792028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of glucocorticoids on renal dopamine production.
    Aguirre JA; Ibarra FR; Barontini M; Arrizurieta EE; Armando I
    Eur J Pharmacol; 1999 Apr; 370(3):271-8. PubMed ID: 10334502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of catechol-O-methyltransferase inhibitors and L-3,4-dihydroxyphenylalanine with or without carbidopa on extracellular dopamine in rat striatum.
    Kaakkola S; Wurtman RJ
    J Neurochem; 1993 Jan; 60(1):137-44. PubMed ID: 8417137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma levels and renal clearance of two isomers of dopamine sulfate in patients with essential hypertension.
    Hashizume K; Ogihara T; Yamatodani A; Yamamoto T; Wada H; Kumahara Y
    Clin Exp Hypertens A; 1988; 10(4):561-74. PubMed ID: 3390960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [An increase in renal dopamine production after the administration of radiographic contrast agents].
    Santos J; Araújo V; Moura L; Serrão P; Guerra L; Maciel J; Pestana M
    Rev Port Cardiol; 1998 Dec; 17(12):1007-11. PubMed ID: 9973862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patients with essential hypertension have an exaggerated natriuretic response to the dopamine pro-drug glutamyl-dopa.
    Worth DP; Harvey JN; Brown J; Lee MR
    J Hypertens Suppl; 1985 Dec; 3(3):S179-81. PubMed ID: 2856699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status.
    O'Connell DP; Ragsdale NV; Boyd DG; Felder RA; Carey RM
    Hypertension; 1997 Jan; 29(1 Pt 1):115-22. PubMed ID: 9039090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aging, high salt intake, and renal dopaminergic activity in Fischer 344 rats.
    Vieira-Coelho MA; Hussain T; Kansra V; Serrao MP; Guimaraes JT; Pestana M; Soares-Da-Silva P; Lokhandwala MF
    Hypertension; 1999 Oct; 34(4 Pt 1):666-72. PubMed ID: 10523344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension.
    Carey RM; Stote RM; Dubb JW; Townsend LH; Rose CE; Kaiser DL
    J Clin Invest; 1984 Dec; 74(6):2198-207. PubMed ID: 6150942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats.
    Rose S; Jenner P; Marsden CD
    Mov Disord; 1988; 3(2):117-25. PubMed ID: 3221899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.